Home · Blog · Research

Bipolar Disorder's Cognitive Decline Linked to Insulin Resistance

Bipolar Disorder's Cognitive Decline Linked to Insulin Resistance

New research reveals that insulin resistance, a metabolic dysfunction, specifically drives gray matter loss and cognitive decline in bipolar disorder (BD), but not in major depressive disorder (MDD). This discovery opens the door for personalized treatments targeting the metabolic roots of cognitive symptoms.

The Research

Published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging by Elsevier, the study led by Dr. Elena Mazza at IRCCS Ospedale San Raffaele in Milan examined 78 patients with MDD and 81 with BD. Researchers combined metabolic biomarkers, brain imaging, and cognitive tests to explore links between insulin resistance, brain structure, and cognition. They found that BD patients had a more severe metabolic profile, including insulin resistance and leptin dysregulation, which correlated with a greater number of mood episodes. Importantly, metabolic dysfunction was associated with reduced gray matter volume in memory and executive function regions, explaining poorer performance in attention, memory, and executive tasks—effects seen only in BD, not MDD.

Why It Matters

For people with bipolar disorder, cognitive symptoms like poor concentration and memory often persist even after mood stabilizes. This study shows that insulin resistance may be a hidden driver, attacking brain structure and function independently of mood episodes. Understanding this metabolic link suggests that addressing insulin resistance—through diet, exercise, or medications like GLP-1 agonists (e.g., semaglutide)—could help protect cognitive abilities and improve daily functioning.

What You Can Do

If you have bipolar disorder or are concerned about your cognitive health, talk to your doctor about screening for insulin resistance (e.g., fasting glucose, HbA1c, or HOMA-IR). Lifestyle changes such as a balanced diet, regular exercise, and stress management can improve insulin sensitivity. For researchers, this pathway highlights the need for clinical trials testing metabolic interventions in BD.

Source: Neuroscience News

Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.

Curious about your own IQ?

Take our free, scientifically designed adaptive test across 7 cognitive domains. No signup required.

Take the free test